Proteomics as a fundamental tool for subclinical screening, tests verification and assessment of applied therapy

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 1, 2013, Pages 65-71

  Suchkov, S V ^a,b   Kostushev, D S ^a   Krynskiy, S A ^a   Gnatenko, D A ^a   Paltsev, M A ^c  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^c RRC Kurchatove Institute   (Russian Federation)

Author keywords

Diagnostics; Prediction; Proteomics; Translation medicine

Indexed keywords

PLASMA PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; HUMAN; LUNG DISEASE; METABOLISM; METHODOLOGY; NEOPLASM; PHYSIOLOGIC MONITORING; PROTEOMICS; TRANSLATIONAL RESEARCH;

BLOOD PROTEINS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; LUNG DISEASES; MONITORING, PHYSIOLOGIC; NEOPLASMS; PROTEOMICS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84890349129     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: 10.15690/vramn.v68i1.540     Document Type: Article

References (13)

1. Alaoui-Jamali M.A., Xu Y.J. Proteomic technology for biomarker profiling in cancer an update. J. Zhejiang. Univ. Sci. B. 2006; 6:411-420.
2. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics. 2002; 11:845-867.
3. Sturgeon C. Perspectives in clinical proteomics conference: translating clinical proteomics into clinical practice. Exp. Rev. Proteomics. 2010;4:469-471.
4. McGregor E., Dunn M.J. Proteomics of heart disease. Hum. Mol. Genet. 2003;2:135-144.
5. Edwards A.V., White M.Y., Cordwell S.J. The role of proteomics in clinical cardiovascular biomarker discovery. Mol. Cell Proteomics. 2008; 10:1824-1837.
6. Bowler R.P., Ellison M.C, Reisdorph N. Proteomics in pulmonary medicine. Chest. 2006; 2: 567-574.
7. David P. Carbone, Harvey I. Pass, David H. Johnson. Principles and Practice of Lung Cancer The Official Reference Text of the LASIX. ISBN 0781773652, 9780781773652.
8. Lemon W.J. et al. Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays. J Med Genet. 2002; 39: 644-655.
9. Gu Y.M. Elevated thymosin beta15 expression is associated with progression and metastasis of non-small cell lung cancer. APMIS. 2008 Jun; 116 (6): 484-90.
10. Brennan D.J., O'Connor D.P., Rexhepaj E., Ponten F. Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat. Rev. Cancer. 2010; 9: 605-617.
11. Golemis E. Protein-protein interactions: A molecular cloning manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. Ix. 2002. 682 p.
12. Phizicky E.M., Fields S. Protein-protein interactions: Methods for detection and analysis. Microbiol. Rev. 1995; 59:94-123.
13. Berggard T., Linse S., James P. Methods for the detection and analysis of protein-protein interactions. Proteomics. 2007; 16: 2833-2842.